Stocks in Hong Kong fell 64 points or 0.2% to 26,587 on Tuesday morning deals, reversing Monday’s rally as consumer shares led losses. Investor caution grew ahead of key Chinese data releases, including October credit growth, industrial output, and retail sales. Sentiment was further weighed down by uncertainty over the U.S. Senate vote to end the record 41-day government shutdown, with voting still underway even as Reuters reported a resolution was near. However, declines were limited by strength in mainland equities, which hit a decade high on Monday after weekend data showed easing producer price deflation and consumer prices turning positive for the first time in eight months. Locally, Hong Kong’s final Q3 GDP figures are due later this week and may show modest improvement, as suggested by flash estimates. Early laggards in Hong Kong included Hansoh Pharma (-2.7%), Wuxi Biologics (-1.9%), and Sino Biopharma (-1.6%).
